An MS Patient Loses Trust When She Finds Out Her Doctor Is Paid By Drug Companies
December 16, 2011
Health Affairs
By Maran Wolston
Last year, four years after showing initial symptoms of multiple sclerosis (MS), I walked out the door of one neurologist’s office and, after several months of searching, switched to a different doctor. It was the final act in a series of events that had gradually eroded my trust in the first neurologist’s judgment, which I believe was colored by his financial relationships with drug companies who manufacture and market medicines for MS patients. Read more
